NDC 73475-1221 – VYVGART Hytrulo
Efgartigimod Alfa 200 mg/mL; Hyaluronidase (human Recombinant) 2000 U/mL · Injection, Solution · Subcutaneous
Product NDC73475-1221
Product details
- Brand name
- VYVGART Hytrulo
- Generic name
- Efgartigimod alfa and hyaluronidase (human recombinant)
- Labeler
- argenx US
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761304
- Marketed since
- April 10, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Endoglycosidase; Neonatal Fc Receptor Blocker
Active ingredients
- Efgartigimod Alfa 200 mg/mL
- Hyaluronidase (human Recombinant) 2000 U/mL
Uses, dosage, side effects and warnings for VYVGART Hytrulo →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 73475-1221-1 | 1 SYRINGE, GLASS in 1 CARTON (73475-1221-1) / 5 mL in 1 SYRINGE, GLASS | Apr 10, 2025 |
| 73475-1221-4 | 4 SYRINGE, GLASS in 1 CARTON (73475-1221-4) / 5 mL in 1 SYRINGE, GLASS | Apr 10, 2025 |
Other VYVGART Hytrulo products
- 73475-3102 Efgartigimod Alfa 180 mg/mL; Hyaluronidase (human Recombinant) 2000… · Injection, Solution · argenx US